NEW YORK, Feb.21 (GenomeWeb News) - The Global Alliance for TB Drug Development and BG Medicine announced today a collaborative deal to identify biomarkers for tuberculosis drug development.
The collaboration will last six months, the partners said.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.